A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture

Hand

Volumn 6, Issue 3, 2011, Pages 250-255

  Chen, Neal C ^a   Srinivasan, Ramesh C ^b   Shauver, Melissa J ^b   Chung, Kevin C ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Complications; Dupuytren's contracture; Evidence; Outcomes; Systematic review

Indexed keywords

EID: 80051470176     PISSN: 15589447     EISSN: 15589455     Source Type: Journal    
DOI: 10.1007/s11552-011-9326-8     Document Type: Review

References (18)

1. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000; 25: 629-36.
2. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007; 32: 767-74.
3. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002; 27: 788-98.
4. Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr. 1993; 60: 808-13.
5. Balaguer T, David S, Ihrai T, Cardot N, Daideri G, Lebreton E. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur. 2009; 34: 493-6.
6. Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease-a systematic review. J Hand Surg Eur. 2010; 35: 623-6.
7. Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am. 2005; 30: 1021-5.
8. Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg Br. 2005; 30: 563-6.
9. Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006; 57: 13-7.
10. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003; 28: 427-31.
11. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009; 361: 968-79.
12. Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg Am. 2007; 32: 240-5.
13. Mushlin AI, Ghomrawi H. Health care reform and the need for comparative-effectiveness research. N Engl J Med. 2010; 362: e6.
14. Rombouts JJ, Noel H, Legrain Y, Munting E. Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification. J Hand Surg Am. 1989; 14: 644-52.
15. Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg Am. 2000; 25: 291-6.
16. Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009; 91: 374-8.
17. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006; 31: 717-25.
18. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010; 35: 534-9. 9. e1.